Walmart stock barely moves after the bell as Fed week takes over — what traders watch next
27 January 2026
1 min read

Walmart stock barely moves after the bell as Fed week takes over — what traders watch next

New York, Jan 26, 2026, 18:44 EST — After-hours

  • Walmart shares edged slightly lower following the close, showing little movement throughout the day.
  • All eyes are on the Fed’s Jan. 27-28 meeting amid growing scrutiny of the central bank.
  • Walmart’s upcoming catalyst is its quarterly report and outlook, due February 19.

Walmart shares slipped slightly in after-hours trading Monday, staying close to their closing price as investors zeroed in on an upcoming Federal Reserve decision that could shift rate expectations and risk sentiment.

The stock has held firm amid a market flipping between growth and defensive plays. With the Fed meeting kicking off Tuesday, even steady names like Walmart could see volatility as bond yields and sentiment shift.

Walmart ended the day down 0.07% at $117.65 and was last seen trading at $117.64 in after-hours. During the session, the shares fluctuated between $117.41 and $118.82. 1

The wider market edged higher, yet retail stocks showed weakness. Target dropped 3.83%, Costco was down 0.57%, and Amazon slipped 0.31%. This came despite the S&P 500 climbing 0.50% and the Dow adding 0.64%. 2

Markets widely expect the Fed to hold its benchmark rate steady this week, keeping it within the 3.50%-3.75% band. Yet political tensions are mounting, with fresh scrutiny on the Fed’s autonomy. Tim Duy, chief U.S. economist at SGH Macro Advisors, remarked, “Trump will need greater turnover at the Fed to fully control the institution.” 3

The meeting is set for Jan. 27-28, and Chair Jerome Powell will speak Wednesday following the decision. 4

Walmart traders have a key date to watch: earnings. The retail giant will report its fiscal 2026 fourth-quarter results on Feb. 19 at 7:00 a.m. Central time, with a conference call to follow. 5

Investors are tuning in to Walmart’s update on traffic and pricing as the new fiscal year begins, watching closely to see how much of its sales growth stems from trade-down shoppers versus wealthier customers.

But the setup works both ways. Should bond yields spike on hawkish signals — or if Fed drama spills into the markets — the defensive support behind big retailers could break down fast, even without any specific company news.

The immediate focus turns to Wednesday’s Fed statement and press conference. For Walmart, eyes will be on Feb. 19, when management is set to discuss demand and margins heading into spring.

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Costco stock price slips after hours as investors circle Feb sales update and March earnings
Previous Story

Costco stock price slips after hours as investors circle Feb sales update and March earnings

ServiceNow stock pops after hours as earnings loom — what Wall Street will watch
Next Story

ServiceNow stock pops after hours as earnings loom — what Wall Street will watch

Go toTop